FREND™ COVID-19 Neutralization Ab
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 08809317541075
- Basic UDI-DI Code
- B-08809317541075
- Reference
- FRCON 020
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- NanoEntek, Inc.
Additional Description
The FREND™ COVID-19 Neutralization Ab is a point-of-care testing (POCT) which can be used to check whether a patient has developed the immune response to SARS-CoV-2 using human serum and plasma (EDTA). The FREND™ COVID-19 Neutralization Ab is a fluorescence immunoassay (FIA) using the FREND™ System intended for the qualitative detection of neutralization antibodies to SARS-CoV-2. The FREND™ COVID-19 Neutralization Ab is an in vitro diagnostic medical device which is intended for use as an aid in identifying individuals with neutralizing antibodies to SARS-CoV-2 after vaccination or prior infection.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0105040699 | VIRAL ANTIGEN/ANTIBODY DETECTION - OTHER |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).